News for Fennec Pharmaceuticals Inc. (FRX.TO)

On June 5, 2025, Rosty Raykov, a Director at Fennec Pharmaceuticals Inc (FENC), sold 10,000 shares of the company. Following this transaction, the insider now o

RESEARCH TRIANGLE PARK, N.C., June 03, 2025 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (the ”œCompany”) (FENC) (TSX:FRX) today announced that the nomi

Fennec Pharmaceuticals (FENC) successfully elected all six directors at their Annual General Meeting with over 93% approval. Shareholders approved the a

Fennec Pharmaceuticals (FENC) is planning a significant meeting in Toronto on June 4. This gathering is organized by Craig-Hallum and presents an opportunity fo

Shares of Fennec Pharmaceuticals Inc. (FENC) touched a new 52-week high of $8.26 yesterday, driven by the company's optimized sales strategy for its lead product, Pedmark, and its successful expansion into additional markets.

On May 14, 2025, Craig-Hallum analyst Chase Knickerbocker announced an update on the stock rating for Fennec Pharmaceuticals (FENC). The firm maintained its "Bu

Net Product Sales: $8.8 million in Q1 2025, reflecting an 18% growth compared to Q1 2024 and an 11% increase over Q4 2024.Selling and Marketing Expenses: $2.9

May 13, 2025 / 12:30PM GMTOperator Good morning, ladies and gentlemen, and welcome to Fennec Pharmaceuticals' first-quarter 2025 earnings and corporate update c

Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Q1 2025 Earnings Conference Call May 13, 2025 8:30 AM ETCompany ParticipantsRobert Andrade - Chief Financial...

RESEARCH TRIANGLE PARK, N.C., May 08, 2025 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. ( FENC; TSX: FRX), a commercial stage specialty pharmaceutical comp

Fennec Pharmaceuticals (NASDAQ: FENC; TSX: FRX) to announce Q1 2025 results on May 13, 2025, before U.S. markets open. A conference call and webcast wil

Washington-based Aptevo Therapeutics Inc. (APVO) is up over 129 percent in Thursday's pre-market trading. The following are some of the other stocks making big moves in Thursday's pre-market trading.

Washington-based Aptevo Therapeutics Inc. (APVO) is up over 129 percent in Thursday's pre-market trading. The following are some of the other stocks making big moves in Thursday's pre-market trading.

Hong Kong-based Regencell Bioscience Holdings Limited (RGC) is up over 58 percent in Tuesday's pre-market trading. The following are some of the other stocks making big moves in Tuesday's pre-market trading.

Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Q4 2024 Earnings Call Transcript March 10, 2025Fennec Pharmaceuticals Inc. misses on earnings expectations.

Revenue Growth: Approximately 40% increase in revenues over the past 12 months.Net Product Sales (Q4 2024): $7.9 million, with a quarterly growth rate of appro

Stocks extended last week's losses on Monday as concerns over the U.S. economy continue to weigh on the market. The Nasdaq 100 saw the steepest declines, with Tesla, Inc. (NASDAQ:TSLA) and Palantir Technologies, Inc.

Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Q4 2024 Earnings Conference Call March 10, 2025 8:30 AM ETCompany ParticipantsRobert Andrade - CFOJeff Hackman -...

~ Achieved Full-Year PEDMARK® Net Product Sales of $29.6 Million, Up 40% Year-Over-Year, and Generated PEDMARK® Q4 2024 Net Product Sales of $7.9 Million ~